These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 1636708)

  • 1. Neurohormonal mechanism of pancreatic exocrine secretion stimulated by sodium oleate and L-tryptophan in dogs.
    Jo YH; Lee YL; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1992 Jul; 263(1 Pt 1):G12-6. PubMed ID: 1636708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atropine on pancreatic bicarbonate output and plasma concentrations of immunoreactive secretin in response to intraduodenal stimulants.
    Niebel W; Singer MV; Hanssen LE; Goebell H
    Scand J Gastroenterol; 1983 Sep; 18(6):803-8. PubMed ID: 6669945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of pancreatic polypeptide on exocrine pancreas and on release of cholecystokinin and secretin.
    Lonovics J; Guzman S; Devitt PG; Hejtmancik KE; Suddith RL; Rayford PL; Thompson JC
    Endocrinology; 1981 May; 108(5):1925-30. PubMed ID: 7215307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative feedback regulation of pancreatic exocrine secretion in guinea pigs.
    Kim CD; Lee KY; Chang TM; Chey WY
    Pancreas; 1995 Mar; 10(2):173-9. PubMed ID: 7716142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin.
    Konturek SJ; Konturek JW; Lamers CB; Tasler J; Bilski J
    Int J Pancreatol; 1987 Aug; 2(4):223-35. PubMed ID: 2890695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency of pancreatic fluid secretory response to intestinal stimulants in the dog.
    Singer MV
    J Physiol; 1983 Jun; 339():75-85. PubMed ID: 6310094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs.
    Konturek SJ; Jaworek J; Cieszkowski M; Pawlik W; Kania J; Bloom SR
    Am J Physiol; 1983 Jun; 244(6):G590-8. PubMed ID: 6305210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic component in the human pancreatic secretory response to intraintestinal oleate.
    Valenzuela JE; Lamers CB; Modlin IM; Walsh JH
    Gut; 1983 Sep; 24(9):807-11. PubMed ID: 6193036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
    Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
    Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
    Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of protein derivatives on pancreatic secretion and release of secretin and CCK in rats.
    Shimizu K; Shiratori K; Watanabe S; Takeuchi T; Chang TM; Chey WY
    Am J Physiol; 1994 Oct; 267(4 Pt 1):G508-14. PubMed ID: 7943315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exocrine pancreatic secretagogues on circulating somatostatin in dogs.
    Beglinger C; Ribes G; Whitehouse I; Loubatières-Mariani MM; Grötzinger U; Gyr K
    Am J Physiol; 1986 Jan; 250(1 Pt 1):G15-20. PubMed ID: 2867683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans.
    You CH; Chey WY
    Pancreas; 1988; 3(1):99-103. PubMed ID: 3362847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting cholinergic dependence of pancreatic and gallbladder responses to cholecystokinin.
    Strah KM; Pappas TN; Melendez RL; Debas HT
    Am J Physiol; 1986 May; 250(5 Pt 1):G665-9. PubMed ID: 3706528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
    Jyotheeswaran S; Li P; Chang TM; Chey WY
    Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pancreatic juice and trypsin on oleic acid-stimulated pancreatic secretion and plasma secretin in dogs.
    Shiratori K; Jo YH; Lee KY; Chang TM; Chey WY
    Gastroenterology; 1989 May; 96(5 Pt 1):1330-6. PubMed ID: 2703117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency of pancreatic enzyme response to intraduodenal stimulants.
    Singer MV; Solomon TE; Wood J; Grossman MI
    Am J Physiol; 1980 Jan; 238(1):G23-9. PubMed ID: 6153511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.